PSMA-Based Theranostics: A Step-by-Step Practical Approach to Diagnosis and Therapy for mCRPC Patients

被引：36
作者：
Ahmadzadehfar, Hojjat [1 ]
Rahbar, Kambiz [2 ]
Essler, Markus [1 ]
Biersack, Hans Juergen [1 ]
机构：
[1] Univ Hosp Bonn, Dept Nucl Med, Venusberg Campus 1, D-53127 Bonn, Germany
[2] Univ Hosp Munster, Dept Nucl Med, Bonn, Germany
来源：
SEMINARS IN NUCLEAR MEDICINE | 2020年 / 50卷 / 01期
关键词：
RESISTANT PROSTATE-CANCER; GLUTAMATE CARBOXYPEPTIDASE-II; LU-177-PSMA-617 RADIOLIGAND THERAPY; MEMBRANE ANTIGEN PSMA; GA-68-PSMA-11; HBED-CC; UREA-BASED INHIBITORS; RADIATION-DOSIMETRY; BIOCHEMICAL RECURRENCE; PRECLINICAL EVALUATION; RADIONUCLIDE THERAPY;
D O I：
10.1053/j.semnuclmed.2019.07.003
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
To date, several papers have been published about prostate-specific membrane antigen (PSMA)-based radioligand diagnostic and therapeutic approaches. This paper mainly provides information for nuclear medicine physicians that are clinically engaged in the diagnosis and treatment of prostate cancer patients. It aims to present the utility of PSMA imaging and therapy in a step-by-step practical approach; thus, it does not discuss radiochemistry and the molecular basics of PSMA. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码：98 / 109
页数：12
相关论文
共 116 条
[1]   PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions [J].
Afshar-Oromieh, A. ;
Malcher, A. ;
Eder, M. ;
Eisenhut, M. ;
Linhart, H. G. ;
Hadaschik, B. A. ;
Holland-Letz, T. ;
Giesel, F. L. ;
Kratochwil, C. ;
Haufe, S. ;
Haberkorn, U. ;
Zechmann, C. M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (04) :486-495
[2]   [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH [J].
Afshar-Oromieh, A. ;
Haberkorn, U. ;
Eder, M. ;
Eisenhut, M. ;
Zechmann, C. M. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (06) :1085-1086
[3]   Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients [J].
Afshar-Oromieh, Ali ;
Holland-Letz, Tim ;
Giesel, Frederik L. ;
Kratochwil, Clemens ;
Mier, Walter ;
Haufe, Sabine ;
Debus, Nils ;
Eder, Matthias ;
Eisenhut, Michael ;
Schaefer, Martin ;
Neels, Oliver ;
Hohenfellner, Markus ;
Kopka, Klaus ;
Kauczor, Hans-Ulrich ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (08) :1258-1268
[4]   The Clinical Impact of Additional Late PET/CT Imaging with 68Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer [J].
Afshar-Oromieh, Ali ;
Sattler, Lars Peter ;
Mier, Walter ;
Hadaschik, Boris A. ;
Debus, Juergen ;
Holland-Letz, Tim ;
Kopka, Klaus ;
Haberkorn, Uwe .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (05) :750-755
[5]   Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing [J].
Afshar-Oromieh, Ali ;
Hetzheim, Henrik ;
Kuebler, Wolfgang ;
Kratochwil, Clemens ;
Giesel, Frederik L. ;
Hope, Thomas A. ;
Eder, Matthias ;
Eisenhut, Michael ;
Kopka, Klaus ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) :1611-1620
[6]   The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer [J].
Afshar-Oromieh, Ali ;
Avtzi, Eleni ;
Giesel, Frederik L. ;
Holland-Letz, Tim ;
Linhart, Heinz G. ;
Eder, Matthias ;
Eisenhut, Michael ;
Boxler, Silvan ;
Hadaschik, Boris A. ;
Kratochwil, Clemens ;
Weichert, Wilko ;
Kopka, Klaus ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (02) :197-209
[7]   Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer [J].
Afshar-Oromieh, Ali ;
Zechmann, Christian M. ;
Malcher, Anna ;
Eder, Matthias ;
Eisenhut, Michael ;
Linhart, Heinz G. ;
Holland-Letz, Tim ;
Hadaschik, Boris A. ;
Giesel, Frederik L. ;
Debus, Juergen ;
Haberkorn, Uwe .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (01) :11-20
[8]  
Ahmadzadehfar H, 2019, EUR UROL, DOI [10.1016/jeururo.2019.02.028, DOI 10.1016/JEURURO.2019.02.028]
[9]   It is time to move forward into the era of Theranostics [J].
Ahmadzadehfar, Hojjat ;
Essler, Markus .
EJNMMI RESEARCH, 2018, 8
[10]   Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy [J].
Ahmadzadehfar, Hojjat ;
Schlolaut, Stephan ;
Fimmers, Rolf ;
Yordanova, Anna ;
Hirzebruch, Stefan ;
Schlenkhoff, Carl ;
Gaertner, Florian C. ;
Awang, Zool Hilmi ;
Hauser, Stefan ;
Essler, Markus .
ONCOTARGET, 2017, 8 (61) :103108-103116
12345678910